biote Corp. (BTMD)
biote Corp. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
biote Corp. (BTMD) is a Medical - Care Facilities company based in US with a market capitalization of $88.7M. Revenue declined 2.5% year-over-year and the company generated $30.2M in free cash flow. This page tracks BTMD's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 217 employees · IPO Apr 28, 2021
Valuation
Valuation & price
$1.97 · as of May 17, 2026 · -56.7% vs 52w high
2.7
P/E ratio
Latest-FY diluted EPS
—
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$88.7M
Market cap
-2.5%
Revenue growth (YoY)
69.8%
Gross margin
$30.2M
Free cash flow (USD)
$85.8M
Net debt
-8.7%
Share dilution
1/4
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2019 → 2025
Free cash flow by year
2019 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 11, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is biote Corp.'s market cap?
biote Corp. (BTMD) has a market capitalization of $88.7M.
What is BTMD's P/E ratio?
BTMD trades at a price-to-earnings ratio of 2.7, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
Are insiders buying BTMD stock?
SEC Form 4 filings show no open-market insider buys at biote Corp. in the last 90 days (0 sells).
Same arena
Related companies in Medical - Care Facilities
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.